Rybelsus

Rybelsus (semaglutide) is a prescription medication used to treat Type 2 diabetes. The first oral GLP-1 tablet for type 2 diabetes, offering semaglutide's blood sugar benefits in a daily pill rather than an injection.

Mimics GLP-1 to stimulate insulin release, suppress glucagon, and slow gastric emptying, lowering blood sugar.

Commonly reported side effects of Rybelsus include Nausea, Abdominal pain, Diarrhea, Decreased appetite, Vomiting, and Thyroid tumor risk. This is not a complete list — tell your doctor or pharmacist about any side effects you experience.

Yes. Rybelsus carries an FDA Boxed Warning — the agency's most serious safety warning. Read the full prescribing information and talk to your doctor about the risks before starting or changing treatment.

The active ingredient in Rybelsus is semaglutide, which belongs to a class of medicines known as GLP-1 Receptor Agonist.

Rybelsus is manufactured by Novo Nordisk. It was first approved in 2019.

You may be able to lower the cost of Rybelsus by using a free pharmacy discount card or by comparing prices across pharmacies before you fill your prescription. Savings vary by pharmacy and location.